Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
Journals
IJERPH
Special Issues
Atrial Fibrillation Detection and Stroke Prevention
ijerph-logo
Submit to IJERPH Review for IJERPH Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Atrial Fibrillation Detection and Stroke Prevention

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Global Health".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 4389

Special Issue Editors

Dr. Riccardo Proietti

E-Mail Website
Guest Editor
Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua, Via Giustiniani 2, 35121 Padua, Italy
Interests: stroke; cerebrovascular events; silent stroke; dementia; mild cognitive impairment; anticoagulation; non vitamin k oral anticoagulants; atrial fibrillation; cardiac pacing
Special Issues, Collections and Topics in MDPI journals
Dr. Ahmed AlTurki

E-Mail Website
Co-Guest Editor
Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada
Interests: atrial fibrillation; stroke; anticoagulation; cardiac pacing; catheter ablation; non vitamin k oral anticoagulants
Dr. Jacqueline Joza

E-Mail Website
Co-Guest Editor
Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada
Interests: atrial fibrillation; cardiac pacing; catheter ablation; inherited cardiomyopathy; anticoagulation; non vitamin k oral anticoagulants.

Special Issue Information

Dear Colleagues,

Stroke is the most devastating complication of atrial fibrillation (AF). AF is estimated to be the cause of about 15% of all ischemic strokes and increases the risk of stroke by fivefold. The foundation of stroke prevention in AF is anticoagulation. Anticoagulation is highly effective in preventing disabling ischemic cardioembolic strokes. This is a rapidly expanding field with numerous developments. These include the use of anticoagulation in special populations with AF, the role of catheter ablation in reducing the risk of stroke and cardiovascular outcomes, and the use of cardiac-implanted devices and wearable devices for the detection of AF. Understanding the impact of AF detection in general and specific populations is also of paramount importance.

Due to the importance of this topic and its impact on clinical practice, IJERPH is launching a Special Issue titled “Atrial Fibrillation Detection and Stroke Prevention”. We are pleased to invite you and your colleagues to submit your original research articles reporting on recent advances in AF detection and stroke prevention. We also encourage the submission of original manuscripts spanning basic to clinical research and focusing on detection and stroke prevention in AF. We would also like to invite you to submit review articles aimed at providing a comprehensive overview of the recent advances in understanding the impact of AF detection as well as the role of catheter ablation and cardiac devices in the relationship between stroke and AF.

Dr. Riccardo Proietti
Dr. Ahmed AlTurki
Dr. Jacqueline Joza
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • health
  • atrial fibrillation
  • stroke
  • oral anticoagulation
  • non-vitamin-K oral anticoagulants
  • cardiac-implanted devices
  • catheter ablation

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

12 pages, 2116 KiB  
Article
Improving Knowledge and Early Detection of Atrial Fibrillation through a Community-Based Opportunistic Screening Program: What’s Your Beat?
by Abubakar Ibrahim Jatau, Luke R. Bereznicki, Barbara C. Wimmer, Woldesellassie M. Bezabhe and Gregory M. Peterson
Int. J. Environ. Res. Public Health 2022, 19(11), 6860; https://doi.org/10.3390/ijerph19116860 - 03 Jun 2022
Cited by 3 | Viewed by 1841
Abstract
A community-based opportunistic screening program was implemented to (i) improve atrial fibrillation (AF) awareness and detection and (ii) assess the performance of the Microlife WatchBP Home A for detecting AF when used in community screening. Screening sessions were conducted among people aged ≥ [...] Read more.
A community-based opportunistic screening program was implemented to (i) improve atrial fibrillation (AF) awareness and detection and (ii) assess the performance of the Microlife WatchBP Home A for detecting AF when used in community screening. Screening sessions were conducted among people aged ≥ 65 years with no history of AF at public events across Tasmania, Australia. Participants with positive screening results were referred to their general medical practitioner for assessment. The device’s performance was assessed using the positive predictive value. A total of 1704 eligible participants were screened at 79 sessions. Of these people, 50 (2.9%) had a positive screening result. The device correctly identified AF in 22 (46.8%) participants with positive results. Among those with subsequently confirmed AF, 6 (27.3%) had a history of AF but were not aware of the diagnosis, and 16 (72.7%) were identified to have previously undiagnosed AF, with an overall prevalence of 0.9% (95% CI, 0.58 to 1.52). Oral anticoagulation therapy was initiated in 12 (87.5%) eligible participants. The positive predictive value of the device was 46.8% (95% CI, 33.3 to 60.7). Given the relatively low performance of the device, its application in community-based opportunistic screening programs for AF is unlikely to be cost-effective. Full article
(This article belongs to the Special Issue Atrial Fibrillation Detection and Stroke Prevention)
►▼ Show Figures

Graphical abstract

11 pages, 338 KiB  
Article
Paroxysmal and Non-Paroxysmal Atrial Fibrillation in Middle Eastern Patients: Clinical Features and the Use of Medications. Analysis of the Jordan Atrial Fibrillation (JoFib) Study
by Hanna Al-Makhamreh, Nasr Alrabadi, Lubna Haikal, Mohammad Krishan, Noor Al-Badaineh, Osama Odeh, Tawfiq Barqawi, Mohammed Nawaiseh, Ala Shaban, Basil Abdin, Lama Khamies and Ayman Hammoudeh
Int. J. Environ. Res. Public Health 2022, 19(10), 6173; https://doi.org/10.3390/ijerph19106173 - 19 May 2022
Cited by 1 | Viewed by 1751
Abstract
(1) Background: Atrial fibrillation (AF) is the most common arrhythmia causing an increased risk of mortality and morbidity. It is classified into paroxysmal and non-paroxysmal AF depending on the duration and frequency of the episodes. (2) Aims: Our goal was to investigate and [...] Read more.
(1) Background: Atrial fibrillation (AF) is the most common arrhythmia causing an increased risk of mortality and morbidity. It is classified into paroxysmal and non-paroxysmal AF depending on the duration and frequency of the episodes. (2) Aims: Our goal was to investigate and compare the clinical profiles, risk of co-morbidities, the use of oral anticoagulation, and outcomes of patients with paroxysmal and non-paroxysmal AF in inpatient and outpatient settings. (3) Methods: Data were extracted from 28 different hospitals and centers in Jordan with a total of 2160 patients enrolled in the study using an observational non-interventional study model. The clinical features and the use of oral anticoagulants were compared in patients with paroxysmal and non-paroxysmal AF. (4) Results: Paroxysmal AF was documented in 35.6% (769) of the patients and non-paroxysmal types in 63.9% (1380); in addition, the type of AF was unknown in 11 (0.5%) patients. Our results showed that non-paroxysmal AF patients tend to be older with more co-morbidities and higher CHA2DS2-VASC and HAS-BLED scores. They also have higher rates of hypertension and diabetes. Anticoagulant, antiarrhythmic, and diuretic agents, overall, were used more in non-paroxysmal AF than paroxysmal AF. Hospital admissions were also more frequent in non-paroxysmal AF due to various factors, some of which are heart failure, bleeding risk, and COPD. (5) Conclusions: Non-paroxysmal AF is more common among Jordanian AF patients. The prevalence of comorbidities and the use of different types of therapies, especially anticoagulants, were higher in these patients. Full article
(This article belongs to the Special Issue Atrial Fibrillation Detection and Stroke Prevention)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop